Frequent and Simultaneous Epigenetic Inactivation of TP53 Pathway Genes in Acute Lymphoblastic Leukemia
Author Information
Author(s): Vilas–Zornoza Amaia, Agirre Xabier, Martín-Palanco Vanesa, Martín-Subero José Ignacio, San José-Eneriz Edurne, Garate Leire, Álvarez Sara, Miranda Estíbaliz, Rodríguez-Otero Paula, Rifón José, Torres Antonio, Calasanz María José, Cigudosa Juan Cruz, Román-Gómez José, Prósper Felipe
Primary Institution: Clínica Universidad de Navarra, Foundation for Applied Medical Research, University of Navarra, Pamplona, Spain
Hypothesis
Is the TP53 pathway altered by epigenetic mechanisms in patients with Acute Lymphoblastic Leukemia (ALL)?
Conclusion
The study found that hypermethylation of TP53 pathway genes is common in ALL and correlates with poor prognosis.
Supporting Evidence
- 154 genes were methylated in more than 10% of ALL samples.
- 78% of patients had methylation of at least one of the 13 genes implicated in the TP53 pathway.
- Hypermethylation significantly correlated with higher relapse and mortality rates.
Takeaway
This study shows that many genes related to a cancer-fighting pathway are turned off in kids with leukemia, which can make the disease worse.
Methodology
The study analyzed the methylation status of 807 genes in 48 ALL samples at diagnosis and validated findings in a second cohort of 200 patients.
Potential Biases
Potential bias due to the retrospective validation of findings.
Limitations
The study is limited by the number of genes analyzed and the specific cohorts used.
Participant Demographics
The study included 200 newly diagnosed ALL patients, median age 17 years, with 91 children and 109 adults.
Statistical Information
P-Value
p=0.001
Confidence Interval
95% CI: 35.9–66 months
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website